Cargando…
1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
BACKGROUND: Influenza A viruses are responsible for seasonal epidemics and represent a constant pandemic threat. Influenza vaccines induce predominantly antibodies against the head region of hemagglutinin (HA) and are strain specific. Vaccine effectiveness is often suboptimal due to mismatch with dr...
Autores principales: | Pizzuto, Matteo Samuele, Zatta, Fabrizia, Minola, Andrea, Peter, Alessia, Culap, Katja, Bianchi, Siro, Soriaga, Leah, De Marco, Anna, Guarino, Barbara, Passini, Nadia, Hong, David K, Benigni, Fabio, Hebner, Christy, Bonavia, Aurelio, Corti, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777610/ http://dx.doi.org/10.1093/ofid/ofaa439.1416 |
Ejemplares similares
-
631. Preliminary safety and pharmacokinetic profile of VIR-2482: a monoclonal antibody for the prevention of influenza A illness
por: Sager, Jennifer, et al.
Publicado: (2020) -
COLLABORATION AGREEMENT No. K1231
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2005) -
Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein
por: Hellert, Jan, et al.
Publicado: (2020) -
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2021) -
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
por: Park, Young-Jun, et al.
Publicado: (2022)